ID
16363
Description
A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy; ODM derived from: https://clinicaltrials.gov/show/NCT00328432
Link
https://clinicaltrials.gov/show/NCT00328432
Keywords
Versions (2)
- 7/12/16 7/12/16 -
- 7/12/16 7/12/16 -
Uploaded on
July 12, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00328432
Eligibility Breast Cancer NCT00328432
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Hormone replacement therapy Before Biopsy
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0282402
- UMLS CUI [1,2]
- C0332152
- UMLS CUI [1,3]
- C0005558
Description
Tamoxifen | Raloxifene | Administration Duration
Data type
boolean
Alias
- UMLS CUI [1]
- C0039286
- UMLS CUI [2]
- C0244404
- UMLS CUI [3,1]
- C1533734
- UMLS CUI [3,2]
- C0449238
Description
Metastatic Neoplasm Evidence of
Data type
boolean
Alias
- UMLS CUI [1,1]
- C2939420
- UMLS CUI [1,2]
- C0332120
Description
Asthma | Hypersensitivity Aspirin | Anti-Inflammatory Agents, Non-Steroidal | celecoxib | Cyclooxygenase 2 Inhibitors | Condition Non-Malignant chronic | Low Dose ASA
Data type
boolean
Alias
- UMLS CUI [1]
- C0004096
- UMLS CUI [2,1]
- C0020517
- UMLS CUI [2,2]
- C0004057
- UMLS CUI [3]
- C0003211
- UMLS CUI [4]
- C0538927
- UMLS CUI [5]
- C1257954
- UMLS CUI [6,1]
- C0348080
- UMLS CUI [6,2]
- C1518371
- UMLS CUI [6,3]
- C0205191
- UMLS CUI [7]
- C0721444
Description
celecoxib Use of | rofecoxib Use of
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0538927
- UMLS CUI [1,2]
- C1524063
- UMLS CUI [2,1]
- C0762662
- UMLS CUI [2,2]
- C1524063
Description
Gastrointestinal ulcer Requirement Therapeutic procedure | Ulcerative Colitis Requirement Therapeutic procedure
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0237938
- UMLS CUI [1,2]
- C1514873
- UMLS CUI [1,3]
- C0087111
- UMLS CUI [2,1]
- C0009324
- UMLS CUI [2,2]
- C1514873
- UMLS CUI [2,3]
- C0087111
Description
Anticoagulants
Data type
boolean
Alias
- UMLS CUI [1]
- C0003280
Description
Antihormone Therapy Neoadjuvant | Chemotherapy Neoadjuvant
Data type
boolean
Alias
- UMLS CUI [1,1]
- C2986607
- UMLS CUI [1,2]
- C0600558
- UMLS CUI [2,1]
- C0392920
- UMLS CUI [2,2]
- C0600558
Description
Aromatase Inhibitors
Data type
boolean
Alias
- UMLS CUI [1]
- C0593802
Description
Lithium
Data type
boolean
Alias
- UMLS CUI [1]
- C0023870
Description
Blood Coagulation Disorder Significant
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0005779
- UMLS CUI [1,2]
- C0750502
Similar models
Eligibility Breast Cancer NCT00328432
- StudyEvent: Eligibility
C0154084 (UMLS CUI [2])
C1318309 (UMLS CUI [3])
C0184921 (UMLS CUI [4])
C3258246 (UMLS CUI [5])
C1879533 (UMLS CUI [1,2])
C0444070 (UMLS CUI [2,1])
C0205410 (UMLS CUI [2,2])
C0015195 (UMLS CUI [2,3])
C1301732 (UMLS CUI [1,2])
C0244404 (UMLS CUI [2])
C1533734 (UMLS CUI [3,1])
C0449238 (UMLS CUI [3,2])
C0332152 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,3])
C0244404 (UMLS CUI [2])
C1533734 (UMLS CUI [3,1])
C0449238 (UMLS CUI [3,2])
C0332120 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0004057 (UMLS CUI [2,2])
C0003211 (UMLS CUI [3])
C0538927 (UMLS CUI [4])
C1257954 (UMLS CUI [5])
C0348080 (UMLS CUI [6,1])
C1518371 (UMLS CUI [6,2])
C0205191 (UMLS CUI [6,3])
C0721444 (UMLS CUI [7])
C1524063 (UMLS CUI [1,2])
C0762662 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0009324 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
C0600558 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0600558 (UMLS CUI [2,2])
C0750502 (UMLS CUI [1,2])